MHLW Grants Approval for Thoracic Surgery Use of Medicaroid’s hinotori™

Medicaroid Corporation has announced that it has obtained regulatory approval from the Japanese Ministry of Health, Labor, and Welfare (MHLW) for utilizing the hinotori Surgical Robot System in thoracic surgery.

The hinotori, a Japanese-made robotic-assisted surgery system, previously received regulatory approval in Japan for urology in August 2020, and for gastroenterology and gynecology in October 2022. Currently, it is operational in various facilities across Japan. This recent approval broadens the hinotori’s scope to encompass thoracic surgery. The hinotori Surgical Robot System will persist in facilitating patient-friendly minimally invasive surgeries.

Through its medical robots, Medicaroid aims to uphold a society where patients, their families, and healthcare professionals can thrive with peace of mind.

© Medicaroid Corporation

Post a comment

Your email address will not be published. Required fields are marked *

Recent News

Successful completion of the inaugural shoulder arthroplasty surgeries utilizing Stryker’s Blueprint® Mixed Reality Guidance System occurred at Mayo Clinic in Minnesota and St. Joseph’s Health Care in London, Canada.

Medical Device Technologies Market is projected to increase from USD 4.20 Billion in 2022 to USD 16.32 Billion by 2030, reflecting a robust Compound Annual Growth Rate (CAGR) of 18.50% over the forecast period

Hodess Cleanroom Construction expands its cleanroom services capabilities with the acquisitions of Protocol Management Services and Clean Rooms West

Medtronic Will Invest Up to $75 Million And begin Co-Promotion For CathWorks’ FFRangio System In The U.S. Europe and Japan

Tornier Shoulder Arthroplasty Portfolio Introduced by Stryker, With New Tornier Perform Humeral System Launched in Europe